Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
37908
CAS Number:
29094-61-9
Glipizide
Purity:
≥ 98 % (dosage par titration, HPLC)
Synonym(s):
N- [4-(3-cyclohexylureidosulfonyl)phénéthyl]-5-méthyl-2-pyrazinecarboxamide
Documents
$129.19 /1G
Taille
Request Bulk Quote
Informations sur le produit

Glipizide is a potent sulfonylurea medication primarily used in the management of type 2 diabetes mellitus. This compound functions by stimulating insulin secretion from pancreatic beta cells, thereby effectively lowering blood glucose levels. Its unique structure, featuring a pyrazine ring and a cyclohexylcarbamoyl group, enhances its efficacy and selectivity, making it a preferred choice among healthcare professionals. Glipizide is often utilized in combination with other antidiabetic agents to achieve optimal glycemic control, and its rapid absorption allows for flexible dosing, catering to individual patient needs.

In addition to its primary use in diabetes management, Glipizide has shown potential in research settings, particularly in studies exploring the mechanisms of insulin secretion and glucose metabolism. Its favorable pharmacokinetic profile and minimal side effects make it a valuable compound in both clinical and research applications. As a reliable option for patients requiring effective blood sugar management, Glipizide stands out for its proven track record and versatility in therapeutic use.

Numéro CAS 
29094-61-9
Formule moléculaire
C21H27N5O4S
Poids moléculaire 
445.54
Point de fusion 
206 °C
Informations générales
Numéro CAS 
29094-61-9
Formule moléculaire
C21H27N5O4S
Poids moléculaire 
445.54
Point de fusion 
206 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Glipizide is widely utilized in research focused on:

  • Diabetes Management: Primarily used as an oral hypoglycemic agent, it helps control blood sugar levels in patients with type 2 diabetes, making it essential in endocrinology and diabetes care.
  • Pharmaceutical Development: Researchers explore its efficacy and safety profiles, aiding in the development of new formulations or combination therapies to enhance patient outcomes.
  • Clinical Studies: Frequently involved in clinical trials to assess its long-term effects and interactions with other medications, providing valuable data for healthcare professionals.
  • Patient Education: Used in educational programs for patients to understand the importance of medication adherence and lifestyle changes in managing diabetes effectively.
  • Comparative Effectiveness Research: Studies comparing glipizide with other diabetes medications help healthcare providers make informed decisions about treatment options tailored to individual patient needs.

Citations